Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.7 |
mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.078 | 0.7 |
mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |